top of page

miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome

About the study

NCT Trial Number

NCT02418195

The drug being studied

Ketamine

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

University of Alabama at Birmingham|National Institute of Mental Health (NIMH)

noun_date_3237048.png

Trial Start Date

Apr-15

noun_capsule_138144.png

About the participants

Age seeking

18 Years to 65 Years

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Depression

noun_square_138133.png

Accepts healthy volunteers?

Yes

The study is to examine the brain mechanisms underpinning treatment outcomes to ketamine.

Eyes Graffiti

Locations

United States, Alabama
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294

Contact: Samantha White, BS, CCRC
205-934-9189
swwhite@uabmc.edu

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page